Envista Holdings NVST
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$13.45M (4 inflow days, 16 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 33.0% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 6.00% to 6.06% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Ilex Capital Partners (Uk) LLP | Hedge Fund | 2026/Q3 | +3,178,019 | 4.7% |
| American Century Investment Management | Mutual Fund | 2026/Q3 | +2,253,111 | 3.3% |
| Los Angeles Capital Management LLC | Mutual Fund | 2026/Q3 | +1,322,667 | 1.3% |
| UBS Asset Management | Mutual Fund | 2026/Q3 | +768,829 | 2.1% |
| Boston Partners Global Investors, Inc. | Mutual Fund | 2026/Q3 | +454,324 | 0.9% |
| BlackRock | Mutual Fund | 2026/Q3 | +450,483 | 11.8% |
| Edgestream Partners, L.P. | Hedge Fund | 2026/Q3 | +351,782 | 0.2% |
| FMR | Mutual Fund | 2026/Q3 | +347,841 | 1.0% |
| Acadian Asset Management LLC | Mutual Fund | 2026/Q3 | +281,851 | 0.2% |
| Ilex Capital Partners (Uk) LLP | Hedge Fund | 2026/Q3 | +4,372,709 | 2.7% |
| Neuberger Berman Investment Advisers LLC | Mutual Fund | 2026/Q3 | +3,864,108 | 2.4% |
| Arrowstreet Capital, Limited Partnership | Mutual Fund | 2026/Q3 | +1,989,647 | 3.0% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +1,625,360 | 1.1% |
| Point72 Asset Management, L.P. | Hedge Fund | 2026/Q3 | +1,563,395 | 1.0% |
| Quantinno Capital Management LP | Mutual Fund | 2026/Q3 | +1,499,916 | 2.6% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 31 Oct 2026 | Paul Keel | Chairperson & CEO | Sale to Issuer | -54,197 | $23.51 | 201,075 |
| 24 Aug 2026 | Robert Befidi | Senior VP & President of Diagnostics | Sale to Issuer | -5,147 | $27.47 | 28,192 |
| 24 Aug 2026 | Eric Hammes | Senior Vice President | Sale to Issuer | -10,885 | $27.47 | 51,976 |
| 24 Aug 2026 | Veronica Acurio | Senior VP & President of Orthodontics | Sale to Issuer | -7,710 | $27.47 | 19,189 |
| 24 Aug 2026 | Stefan Nilsson | President of Nobel Biocare | Sale to Issuer | -804 | $27.47 | 31,943 |
| 19 Aug 2026 | Mischa Reis | Senior Vice President of Strategy & Corporate Development | Automatic Disposition | -8,000 | $27.50 | 27,321 |
| 17 Aug 2026 | Paul Keel | Chairperson & CEO | Other Acquisition | +179,730 | – | 396,489 |
| 17 Aug 2026 | Paul Keel | Chairperson & CEO | Other Derivative Acquisition | +159,900 | – | 159,900 |
| 17 Aug 2026 | Eric Hammes | Senior Vice President | Other Derivative Acquisition | +47,970 | – | 47,970 |
| 5 Aug 2026 | Coree Thomas | Vice President | Initial Statement of Beneficial | +0 | – | 2,535 |
| 24 May 2026 | Paul Keel | Chairperson & CEO | Sale to Issuer | -12,811 | $23.43 | 154,815 |
| 18 May 2026 | Daniel Raskas | Independent Director | Other Acquisition | +9,330 | – | 54,010 |
| 18 May 2026 | Christine Tsingos | Independent Director | Other Acquisition | +9,330 | – | 19,780 |
| 18 May 2026 | Kieran Gallahue | Independent Director | Other Acquisition | +9,330 | – | 54,010 |
| 18 May 2026 | Richard Huennekens | Lead Independent Director | Other Acquisition | +12,585 | – | 82,105 |
| 18 May 2026 | Vivek Jain | Independent Director | Other Acquisition | +9,330 | – | 52,945 |
| 18 May 2026 | Wendy Carruthers | Independent Director | Other Acquisition | +9,330 | – | 59,930 |
| 18 May 2026 | J. Pierce | Independent Director | Other Acquisition | +9,330 | – | 18,485 |
| 24 Feb 2026 | Paul Keel | Chairperson & CEO | Sale to Issuer | -11,840 | $29.59 | 143,881 |
| 24 Feb 2026 | Paul Keel | Chairperson & CEO | Other Acquisition | +48,670 | – | 240,504 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 9,728,394 | 6.1% | 3.0 |
| 15 Oct 2026 | 9,773,910 | 6.1% | 4.1 |
| 30 Sep 2026 | 12,072,597 | 7.5% | 3.6 |
| 15 Sep 2026 | 10,210,406 | 6.4% | 4.0 |
| 31 Aug 2026 | 11,382,180 | 7.1% | 5.5 |
| 14 Aug 2026 | 9,634,725 | 6.0% | 2.6 |
No comments yet — be the first to weigh in on NVST.
Sign in to join the discussion.